Literature DB >> 1686719

Mechanisms of resistance to cisplatin.

A Eastman.   

Abstract

A number of changes have been detected in cisplatin-resistant cells, some of which are likely to be directly involved in the mechanism of resistance. The four most cited mechanisms are reduced accumulation, increased glutathione, increased metallothionein, and enhanced DNA repair. Of these mechanisms, reduced accumulation is probably the most common. Detoxification by glutathione or metallothionein may occur in some circumstances, but the evidence is often ambivalent. Enhanced DNA repair has been observed in several cases, but, to date, few cell lines have been adequately investigated for such changes. These observations demonstrate that multiple mechanisms of resistance exist, and often several may occur in the same cell line. To understand the significance of specific mechanisms, many laboratories are attempting to obtain genetic probes. These probes will then be used to clarify the mechanisms of resistance in fresh clinical samples and hopefully will facilitate improvements in therapeutic response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686719     DOI: 10.1007/978-1-4615-3872-1_11

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  5 in total

1.  Cytoplasmic initiation of cisplatin cytotoxicity.

Authors:  Fang Yu; Judit Megyesi; Peter M Price
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-09

2.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.

Authors:  Yonit Kasherman; Stefan Sturup; Dan Gibson
Journal:  J Biol Inorg Chem       Date:  2008-12-04       Impact factor: 3.358

3.  Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway.

Authors:  Yan Wang; Lei Chen; Guochang Huang; Dongmei He; Juan He; Wei Xu; Chunying Zou; Feng Zong; Yan Li; Bo Chen; Shuanshuan Wu; Weihong Zhao; Jianqing Wu
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

4.  Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drug.

Authors:  Lauren Amable; Jason Fain; Elaine Gavin; Eddie Reed
Journal:  Oncol Rep       Date:  2014-06-12       Impact factor: 3.906

5.  Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.

Authors:  Danyang Zhou; Wenjing Liu; Songhe Liang; Banghao Sun; Anqi Liu; Zhongqi Cui; Xue Han; Lijie Yuan
Journal:  Cancer Med       Date:  2018-03-09       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.